Solriamfetol Hydrochloride News
Solriamfetol Hydrochloride currently has 0 news articles, with 20 predicted indications.
This page combines the AI-predicted indications for Solriamfetol Hydrochloride with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Original indication: Sunosi is indicated to improve wakefulness and reduce excessive daytime sleepiness in adult patients with narcolepsy (with or without cataplexy). Sunosi is indicated to improve wakefulness and reduce...
- Evidence level: L5
- Predicted indications (20):
- attention deficit-hyperactivity disorder (100.0%)
- faciodigitogenital syndrome (100.0%)
- insomnia (disease) (100.0%)
- attention deficit hyperactivity disorder, inattentive type (100.0%)
- chondromyxoid fibroma (99.9%)
- specific developmental disorder (99.9%)
- variably protease-sensitive prionopathy (99.9%)
- multiple system atrophy (99.9%)
- X-linked adrenoleukodystrophy (99.8%)
- postural orthostatic tachycardia syndrome (99.8%)
- disorder of peroxisomal alpha-, beta- and omega-oxidation (99.8%)
- narcolepsy (99.8%)
- narcolepsy-cataplexy syndrome (99.8%)
- Creutzfeldt-Jakob disease (99.7%)
- ACBD5 deficiency (99.7%)
- narcolepsy, susceptibility to (99.7%)
- megaconial type congenital muscular dystrophy (99.6%)
- hypersomnia (disease) (99.5%)
- circadian rhythm sleep disorder (99.4%)
- Balo concentric sclerosis (99.2%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.